In contrast, GLP-1 receptor agonists lack any established role in RA management
The foods or food components are listed categorically in descending order of confidence that they may negatively affect brain or cognitive function
And when peptides like those endorsed today were tested to see if they would enhance performance by increasing growth hormone secretion, they were shown to be largely ineffective
The general consensus is that any increased risk of retinopathy with GLP-1 RA treatment is likely to be related to the abrupt improvement in glycemic control [108], a phenomenon similar to that reported for other neuropathological complications [109]
Alvarez E, Roncero I, Chowen JA, Vazquez P, Blazquez E
Yau T, Kang YK, Kim TY, El-Khoueiry AB, Santoro A, Sangro B, et al